Wolverine Trading, LLC Medpace Holdings, Inc. Put Options Transaction History

Wolverine Trading, LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $148,800 - $169,736	400 Added 30.77%	1,700 $700,000
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $826,123 - $1.2 Million	-2,900 Reduced 69.05%	1,300 $525,000
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $955,584 - $1.31 Million	4,200 New	4,200 $1.29 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $333,288 - $514,344	-2,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $36,548 - $45,580	200 Added 9.09%	2,400 $526,000
Q3 2021 Nov 12, 2021	BUY	$170.18 - $198.21 $374,396 - $436,062	2,200 New	2,200 $413,000
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $396,060 - $504,780	-3,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$109.38 - $149.19 $328,140 - $447,570	3,000 New	3,000 $414,000
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $231,472 - $325,312	-3,400 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$61.71 - $101.95 $129,591 - $214,095	-2,100 Reduced 38.18%	3,400 $255,000
Q4 2019 Feb 12, 2020	SELL	$70.08 - $84.64 $322,368 - $389,344	-4,600 Reduced 45.54%	5,500 $458,000
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $392,994 - $541,107	-6,300 Reduced 38.41%	10,100 $840,000
Q2 2019 Aug 20, 2019	SELL	$53.64 - $65.42 $702,684 - $857,002	-13,100 Reduced 44.41%	16,400 $1.07 Million
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $1.11 Million - $1.59 Million	22,500 Added 321.43%	29,500 $1.74 Million
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $211,365 - $287,910	-4,500 Reduced 39.13%	7,000 $363,000
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $497,375 - $733,010	11,500 New	11,500 $689,000

653

25.6M

38.7K

79.5K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.